Will a Shields sale boost Walgreens health care plan?: Former CEO Roz Brewer said the specialty pharmacy firm would drive long-term growth. The new boss seems to have other ideas.

Autor:	Davis, Katherine (AUTHOR)
Předmět:	WALGREEN Co., SPECIALTY pharmacies, BUSINESS enterprises, CHIEF executive officers, INVESTORS
Zdroj:	Crain's Chicago Business. 2/12/2024, Vol. 47 Issue 6, p1-1. 1p.
Abstrakt:	Walgreens Boots Alliance, a pharmacy chain, is reportedly looking to sell specialty pharmacy firm Shields Health Solutions for over $4 billion. The sale could help Walgreens refine its health care segment and strengthen its balance sheet. Shields, which was intended to support Walgreens' transition into a full-fledged health care company, only accounted for 7% of the health care segment's sales in 2023. Potential buyers for Shields include other specialty pharmaceutical companies, health systems, or private-equity firms. [Extracted from the article]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.